Home > Education Hub > ISPOR EU 2022

ISPOR EU 2022

6-9 November, 2022 | Vienna, Austria

We were pleased to join ISPOR EU 2022, the leading global conference for Health Economics and Outcomes Research. Our experts will join the event as speakers and presenters for multiple discussion and poster sessions. Learn more about our current ISPOR Europe participation and download posters from past ISPOR events in our Scientific Articles.

Our speaker sessions:

Spotlight session

8th of November, 13:30 – 14:30
The Economics of Survival: A Discussion on the Role of Health Policy, Environmental Policy, & Economic Policy in Healthcare Decision Making

Our moderator
Richard Charter, Vice President MedTech Market Access – Europe & Asia Pacific

If healthcare systems were a country, they would collectively be the 5th largest emitter of greenhouse gases globally. Healthcare decision makers are already grappling with increased demand for healthcare, and highly constrained budgets. However, unless we act immediately the climate emergency will quickly supersede both challenges. As with public health policy, environmental policy is highly influenced by economic decision makers. This panel will have a robust discussion on the intersection of health, environmental, and economic policy and how to enable more sustainable healthcare systems.

Forum session

8th of November, 11:45 – 12:45
HTA & Public Procurement of Medtech Solutions: Building a Bridge for Better Decision Making

Our panelist
Richard Charter, Vice President MedTech Market Access – Europe & Asia Pacific

The objectives of this panel are threefold: first, to update and inform any stakeholder in the Medical Device and Diagnostic ecosystem on current practices involving the usage of HTA reports by procurement decision makers based on a systematic literature review conducted by MD&D SIG members and gaps in knowledge – how procurement uses (or does not use) HTA, and whether HTA uses procurement for their respective decision-making processes. Second, foster an active discussion of research plans to address these knowledge gaps through survey of stakeholders and offer joining this discussion an opportunity to engage in this future research. Third; to engage the panelists and audience how this interaction should evolve going forward. This forum will leave 20 minutes for open discussion after introductory comments from the speakers. Group discussion will be encouraged.

Issue panel

9th of November, 10:00 – 11:00
External Control Arms, Is It the Way to Go?

Our moderator
Catia Proenca, Director in Market Access – RWE
Our speaker
Rajat Mukherjee, VP Adv. Statistics and Data Science

The growing implementation of Single Arm Trials (SAT) with External-Control Arms (ECA) has been the subject of heated debate with some advocating its use when traditional RCTs are unfeasible, while others fear that it is a means to accelerate timelines and limit costs at the expense of robust quality of evidence. Contrasting perspectives on the different uses and applications of ECA will be discussed.

Podium session

7th of November, 16:45PM – 17:00PM (Part of Podium Session “Key Trends in HTA Policy: Present and Future”)
Potential Areas of Focus for the Future EU HTA Methodology: Discrepancies between EUnetHTA Vs National Evaluations
Our speaker
Nuria Rodriguez García, Director, Access and Pricing Europe

The EU HTA framework adopted in 2021 will build on previous EUnetHTA cooperation with the aim to make health technologies more readily available to EU patients through a centralized HTA process. This will ensure faster and predictable processes and avoid duplication of efforts and discrepancies in assessments. The aim of this research is to identify the areas where evaluations between EUnetHTA and country HTA differed and understand whether these areas have driven an impact on the national HTA outcomes.Our research focused on previous EUnetHTA relative effectiveness assessments (REAs) (2016-2021), and corresponding national assessment reports in at least 3 of the selected countries: France, Germany, Italy and Spain. A framework was developed to assess the discrepancies and similarities between the EUnetHTA and national HTAs on 10 assessments items relevant to the population and subgroup analysis, assigned comparators, outcome selection and analysis, and study design issues. We further identified the impact of the discrepancy or similarity on the outcomes of the country assessments.

function session1Function() {
var x = document.getElementById(“session1”);
if (x.style.display === “none”) {
x.style.display = “block”;
} else {
x.style.display = “none”;
}
}

function session2Function() {
var x = document.getElementById(“session2”);
if (x.style.display === “none”) {
x.style.display = “block”;
} else {
x.style.display = “none”;
}
}

function session3Function() {
var x = document.getElementById(“session3”);
if (x.style.display === “none”) {
x.style.display = “block”;
} else {
x.style.display = “none”;
}
}

function session4Function() {
var x = document.getElementById(“session4”);
if (x.style.display === “none”) {
x.style.display = “block”;
} else {
x.style.display = “none”;
}
}

Our posters:

Events

Category:

Published on:

October 18, 2022

Poster: Project Orbis to Accelerate Patient Access to Innovative Cancer Therapies: A Narrative Review

Presenter: Beatriz Massó Authors: Ricci JF, Hurtado P, Demont E, Sathi C, Castañer A, Machuca P, Massó B

Poster: EU Joint Clinical Assessment Initiative: Process and Access Strategy Implications

Presenter: Celia Sathi Authors: Ricci JF, Hurtado P, Demont E, Sathi C, Castañer A, Machuca P, Massó B

Poster: Relationship between the Number of Approved Cancer Treatments and Unmet Need

Presenter: Oscar Dumoulin Authors: Dumoulin O, Bento G, Reinert M & Gulotta G

Poster: Impact of Publication of the French Commission for Economic and Public Health Evaluation (CEESP) Doctrine on the Conclusions of Its Economic Opinions

Presenters: Anne-Line Couillerot Author: Marine Meyer, Malika Belamri, Erwan Autin, Anne-Line Couillerot

Poster: HTA Assessment of Adaptive Trials for Oncology Drugs in Europe

Presenter: Oscar Dumoulin Authors: Bento G, Dumoulin O, Reinert M & Gulotta G

Poster: Best Practices for ECA design to optimize HTA acceptance

Presenter: Alexa Vidalis Authors: Catia Proenca, Oscar Dumoulin, Alexa Vidalis

Poster: Burden of disease in asthma, stratified by EOS levels in the UK

Presenter: Oscar Dumoulin Authors: Catia Proenca, Oscar Dumoulin, Aurelie Martinot, Pepi Hurtado, Mathieu Rose

Poster: Management of the post-surgery hospital care in France according to the type of surgery: a French claims database analysis

Presenter: Nicoleta Petrica Authors: Nicoleta Petrica, Mathieu Rose, Romain Finas

Poster: Impact of Publication of the French Commission for Economic and Public Health Evaluation (CEESP) Doctrine on the Conclusions of Its Economic Opinions

Presenter: Marine Meyer Authors: Marine Meyer, Malika Belamri, Erwan Autin, Anne-Line Couillerot

Poster: Are there specificities for assessing quality of life and utilities in rare diseases for economic evaluation in France: a case study of published CEESP opinions

Presenter: Sarah Sadeuk-Benabbas Authors: Sarah Sadeuk-Benabbas, Erwan Autin, Anne-Line Couillerot, Valérie Clément

Poster: Evolution of the Number of Metastatic Lung Cancer Patients before and during the COVID 19 Pandemic: A French National Hospital Database Analysis

Presenter: Nicoleta Petrica Authors: Batourou Sano, Nicoleta Petrica, Mathieu Rose

Poster: Current and Future Trends in P&R Decisions of Oncology and Onco-Hematology Drugs in Spain: A retrospective and forum discussion study

Presenter: Vázquez Manuel Authors: Vázquez Manuel, Castillo Chus, Bordoy Clara, Cruz Jessica, Manau Marc

Poster: The Catalan Health Service, An Example Where Patients Have Full Medicine Appraisal and Decision-Making Representation

Presenter: Chus Castillo Authors: Vázquez Manuel, Castillo Chus, Bordoy Clara, Cruz Jessica, Manau Marc

Poster: Impact of Independence and Transparency on Drug Availability and Time to Market: EU4 Qualitative and Quantitative Analysis of Pricing, Reimbursement, and Access Processes

Presenter: Castillo Chus Authors: Castillo Chus, Vázquez Manuel, Vico TaniaVidal-Barraquer Eduard